2002
DOI: 10.1016/s0165-6147(00)01884-8
|View full text |Cite
|
Sign up to set email alerts
|

Mouse models of Huntington's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
162
0
2

Year Published

2003
2003
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 266 publications
(170 citation statements)
references
References 86 publications
6
162
0
2
Order By: Relevance
“…Most HD models use huntingtin genes with very long CAG repeats (>100) to induce a robust phenotype (5). To date, no assay in live cells has noted a phenotype at polyglutamine lengths close to 37 repeats or even typical HD repeat lengths.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Most HD models use huntingtin genes with very long CAG repeats (>100) to induce a robust phenotype (5). To date, no assay in live cells has noted a phenotype at polyglutamine lengths close to 37 repeats or even typical HD repeat lengths.…”
Section: Resultsmentioning
confidence: 99%
“…This CAG mutation results in an expanded polyglutamine tract in the amino terminus of the gene's protein product, huntingtin (1). To date, no phenotypes at the level of huntingtin molecular biology or animal models can be attributed to polyglutamine lengths near the human pathogenic disease threshold (5).…”
mentioning
confidence: 99%
“…It is also likely that the full extent of the learning impairments observed here cannot solely be correlated with corticostriatal dysfunction, as hippocampal plasticity or other central and peripheral physiologies have also been shown to be changed in several lines of transgenic mice (19,20), including R6/1 line. However, as the type of procedural learning studied here has been known to require an intact striatum (21), pathologies of other brain areas including the hippocampus are not likely to be primarily associated with the severe learning deficits observed in R6/1 mice.…”
Section: Discussionmentioning
confidence: 98%
“…Chez la drosophile, la huntingtine ne contient ni domaines polyglutamines ni régions riches en proline. Des progrès notables dans la compréhension des mécanismes de la maladie de Huntington ont été réalisés grâce au développement de modèles biochimiques, cellulaires, génétiques et lésionnels [21][22][23]. En particulier, les phénotypes d'inactivation du gène codant pour la huntingtine chez la souris suggèrent que la protéine serait impliquée dans la neurogenèse [19] et dans la survie neuronale à l'âge adulte [20].…”
Section: La Chorée De Huntington Physiopathologieunclassified